NDC 62332-064 – Rivastigmine Tartrate
Rivastigmine Tartrate 3 mg/1 · Capsule · Oral
Product NDC62332-064
Product details
- Brand name
- Rivastigmine Tartrate
- Generic name
- Rivastigmine Tartrate
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA091689
- Marketed since
- June 12, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor
Active ingredients
- Rivastigmine Tartrate 3 mg/1
Uses, dosage, side effects and warnings for Rivastigmine Tartrate →
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 62332-064-10 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62332-064-10) / 10 CAPSULE in 1 BLISTER PACK | Jun 12, 2022 |
| 62332-064-30 | 30 CAPSULE in 1 BOTTLE (62332-064-30) | Jun 12, 2022 |
| 62332-064-60 | 60 CAPSULE in 1 BOTTLE (62332-064-60) | Jun 12, 2022 |
| 62332-064-71 | 500 CAPSULE in 1 BOTTLE (62332-064-71) | Jun 12, 2022 |
| 62332-064-91 | 1000 CAPSULE in 1 BOTTLE (62332-064-91) | Jun 12, 2022 |
Other Rivastigmine Tartrate products
- 62332-063 Rivastigmine Tartrate 1.5 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-065 Rivastigmine Tartrate 4.5 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-066 Rivastigmine Tartrate 6 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-063 Rivastigmine Tartrate 1.5 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-064 Rivastigmine Tartrate 3 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-065 Rivastigmine Tartrate 4.5 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-066 Rivastigmine Tartrate 6 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 60687-777 Rivastigmine Tartrate 1.5 mg/1 · Capsule · American Health Packaging
- 65862-651 Rivastigmine Tartrate 6 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-649 Rivastigmine Tartrate 3 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-650 Rivastigmine Tartrate 4.5 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-648 Rivastigmine Tartrate 1.5 mg/1 · Capsule · Aurobindo Pharma Limited